147 related articles for article (PubMed ID: 19303341)
1. Marked hypertriglyceridemia upon treatment with etanercept.
Haroon M; Devlin J
Joint Bone Spine; 2009 Oct; 76(5):570-1. PubMed ID: 19303341
[No Abstract] [Full Text] [Related]
2. Etanercept, anticytokines and mania.
Kaufman KR
Int Clin Psychopharmacol; 2005 Jul; 20(4):239-41. PubMed ID: 15933486
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
[No Abstract] [Full Text] [Related]
4. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
[No Abstract] [Full Text] [Related]
5. Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis.
Besada E; Njålla RJ; Nossent JC
Rheumatol Int; 2013 Oct; 33(10):2687-9. PubMed ID: 22886470
[TBL] [Abstract][Full Text] [Related]
6. Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study.
Atzeni F; Boccassini L; Antivalle M; Salaffi F; Sarzi-Puttini P
Ann Rheum Dis; 2011 Apr; 70(4):712-4. PubMed ID: 20810394
[No Abstract] [Full Text] [Related]
7. [Therapy of rheumatoid arthritis with etanercept].
Lamprecht P; Nitschmann S
Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
[No Abstract] [Full Text] [Related]
8. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
Paul C; Solignac M
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
[No Abstract] [Full Text] [Related]
9. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
Mikhail M; Weinberg JM; Smith BL
Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
[No Abstract] [Full Text] [Related]
10. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
[TBL] [Abstract][Full Text] [Related]
11. Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years.
Yazici Y; Erkan D; Lockshin MD
Clin Exp Rheumatol; 2002; 20(1):115. PubMed ID: 11892697
[No Abstract] [Full Text] [Related]
12. [Etanercept].
Mühlhäuser U; Münzel F; Eschenhagen T
Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1775-8. PubMed ID: 12934172
[No Abstract] [Full Text] [Related]
13. From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept.
ElKayam O; Yaron M; Caspi D
Ann Rheum Dis; 2000 Oct; 59(10):839. PubMed ID: 11203155
[No Abstract] [Full Text] [Related]
14. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.
Mease PJ
Ann Rheum Dis; 2002 Apr; 61(4):298-304. PubMed ID: 11874829
[TBL] [Abstract][Full Text] [Related]
15. Elevated triglyceride and cholesterol levels after intravenous antitumour necrosis factor-alpha therapy in a patient with psoriatic arthritis and psoriasis vulgaris.
Antoniou C; Dessinioti C; Katsambas A; Stratigos AJ
Br J Dermatol; 2007 May; 156(5):1090-1. PubMed ID: 17408391
[No Abstract] [Full Text] [Related]
16. Paradoxical psoriatic arthritis in a patient with rheumatoid arthritis treated by TNFα blocker.
Villani AP; Weiler L; Jullien D; Chapurlat R; Confavreux C
Joint Bone Spine; 2014 Oct; 81(5):455-6. PubMed ID: 24561024
[No Abstract] [Full Text] [Related]
17. Efficacy of etanercept in lymphedema associated with psoriatic arthritis.
Lekpa FK; Economu-Dubosc A; Fevre C; Claudepierre P; Chevalier X
J Rheumatol; 2009 Jan; 36(1):207-8. PubMed ID: 19208540
[No Abstract] [Full Text] [Related]
18. [Treatment of psoriatic arthritis with TNF alpha-antagonists].
Antoni C; Manger B
Z Rheumatol; 2003 Jun; 62(3):235-9. PubMed ID: 12827399
[TBL] [Abstract][Full Text] [Related]
19. TNFalpha inhibition in psoriatic arthritis: cause for hope.
Zabraniecki L; Fournié B
Joint Bone Spine; 2001 Mar; 68(2):106-8. PubMed ID: 11324924
[No Abstract] [Full Text] [Related]
20. One million U.S. adults may suffer from psoriatic arthritis.
Dermatol Nurs; 2002 Jun; 14(3):207-8. PubMed ID: 12099074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
